BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27550360)

  • 1. Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.
    Zhao Y; Nagasaki Y; Kordalewska M; Press EG; Shields RK; Nguyen MH; Clancy CJ; Perlin DS
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6573-6577. PubMed ID: 27550360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel
    Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
    Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.
    Klotz U; Schmidt D; Willinger B; Steinmann E; Buer J; Rath PM; Steinmann J
    Mycoses; 2016 May; 59(5):312-8. PubMed ID: 26806376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Detection of
    Hou X; Lee A; Jiménez-Ortigosa C; Kordalewska M; Perlin DS; Zhao Y
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397051
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous Mutational Frequency and
    Shields RK; Kline EG; Healey KR; Kordalewska M; Perlin DS; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
    Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
    Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.
    Niimi K; Woods MA; Maki K; Nakayama H; Hatakenaka K; Chibana H; Ikeda F; Ueno K; Niimi M; Cannon RD; Monk BC
    J Antimicrob Chemother; 2012 Jul; 67(7):1666-76. PubMed ID: 22514266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
    Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
    [No Abstract]   [Full Text] [Related]  

  • 10. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.
    Zimbeck AJ; Iqbal N; Ahlquist AM; Farley MM; Harrison LH; Chiller T; Lockhart SR
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5042-7. PubMed ID: 20837754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance.
    Dudiuk C; Gamarra S; Leonardeli F; Jimenez-Ortigosa C; Vitale RG; Afeltra J; Perlin DS; Garcia-Effron G
    J Clin Microbiol; 2014 Jul; 52(7):2609-14. PubMed ID: 24829248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
    Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
    Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
    Katiyar SK; Alastruey-Izquierdo A; Healey KR; Johnson ME; Perlin DS; Edlind TD
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6304-9. PubMed ID: 23027185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
    Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
    Pham CD; Iqbal N; Bolden CB; Kuykendall RJ; Harrison LH; Farley MM; Schaffner W; Beldavs ZG; Chiller TM; Park BJ; Cleveland AA; Lockhart SR
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4690-6. PubMed ID: 24890592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF; Ahmad S; Khan Z
    Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.
    Shields RK; Nguyen MH; Press EG; Kwa AL; Cheng S; Du C; Clancy CJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4862-9. PubMed ID: 22751546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.
    Bordallo-Cardona MÁ; Escribano P; de la Pedrosa EG; Marcos-Zambrano LJ; Cantón R; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.
    Lewis JS; Wiederhold NP; Wickes BL; Patterson TF; Jorgensen JH
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4559-61. PubMed ID: 23817368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.
    Katiyar S; Pfaller M; Edlind T
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2892-4. PubMed ID: 16870797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.